128 related articles for article (PubMed ID: 15642214)
41. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
[TBL] [Abstract][Full Text] [Related]
42. [Nuclear expression of Survivin in glioma and its correlation to prognosis].
Pan Y; Hu WH; Xie D; Wu HX; Xiang J; Liu YD; Wu QL; Liu YH
Ai Zheng; 2006 May; 25(5):635-9. PubMed ID: 16687089
[TBL] [Abstract][Full Text] [Related]
43. [Expression and prognostic value of survivin protein in early-stage non-small cell lung cancer].
Zhu ZH; Yang H; Fu JH; Hu Y; Ma Y; Wu QL; Rong TH; Wang DF
Ai Zheng; 2007 Nov; 26(11):1268-71. PubMed ID: 17991331
[TBL] [Abstract][Full Text] [Related]
44. Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis.
Chen P; Zhu J; Liu DY; Li HY; Xu N; Hou M
Med Oncol; 2014 Jan; 31(1):775. PubMed ID: 24338338
[TBL] [Abstract][Full Text] [Related]
45. [Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma].
Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1626-30. PubMed ID: 17359695
[TBL] [Abstract][Full Text] [Related]
46. Survivin gene expression positively correlates with proliferative activity of cancer cells in esophageal cancer.
Ikeguchi M; Yamaguchi K; Kaibara N
Tumour Biol; 2003; 24(1):40-5. PubMed ID: 12743425
[TBL] [Abstract][Full Text] [Related]
47. [Expression and clinical significance of IGF-II mRNA and bcl-2 protein in colorectal adenocarcinomas].
Zhang MS; Yuan HY; Xiong B; Deng Q; Tang ZJ; Xia D
Ai Zheng; 2002 Nov; 21(11):1226-30. PubMed ID: 12526221
[TBL] [Abstract][Full Text] [Related]
48. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis.
Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C
Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356
[TBL] [Abstract][Full Text] [Related]
49. Expression of survivin and its significance in colorectal cancer.
Chen WC; Liu Q; Fu JX; Kang SY
World J Gastroenterol; 2004 Oct; 10(19):2886-9. PubMed ID: 15334693
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.
Kawasaki H; Altieri DC; Lu CD; Toyoda M; Tenjo T; Tanigawa N
Cancer Res; 1998 Nov; 58(22):5071-4. PubMed ID: 9823313
[TBL] [Abstract][Full Text] [Related]
52. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.
Ikehara M; Oshita F; Kameda Y; Ito H; Ohgane N; Suzuki R; Saito H; Yamada K; Noda K; Mitsuda A
Oncol Rep; 2002; 9(4):835-8. PubMed ID: 12066218
[TBL] [Abstract][Full Text] [Related]
53. [Expression and clinical significance of hypoxia inducible factor-1alpha, survivin and vascular endothelial growth factor in esophageal squamous cell carcinoma].
Zhang HZ; Zhang J; Xu N; Duan XB; He CN
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):689-90. PubMed ID: 18194604
[No Abstract] [Full Text] [Related]
54. [Expression of survivin and its clinical significance in non-small cell lung cancer].
Ren YJ; Zhang QY
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):504-7. PubMed ID: 16224523
[TBL] [Abstract][Full Text] [Related]
55. Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
Kaio E; Tanaka S; Oka S; Hiyama T; Kitadai Y; Haruma K; Chayama K
Int J Oncol; 2003 Oct; 23(4):901-11. PubMed ID: 12963968
[TBL] [Abstract][Full Text] [Related]
56. Cellular localisation of survivin: impact on the prognosis in colorectal cancer.
Ponnelle T; Chapusot C; Martin L; Bouvier AM; Plenchette S; Faivre J; Solary E; Piard F
J Cancer Res Clin Oncol; 2005 Aug; 131(8):504-10. PubMed ID: 15902487
[TBL] [Abstract][Full Text] [Related]
57. p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases.
Belluco C; Guillem JG; Kemeny N; Huang Y; Klimstra D; Berger MF; Cohen AM
J Clin Oncol; 1996 Oct; 14(10):2696-701. PubMed ID: 8874329
[TBL] [Abstract][Full Text] [Related]
58. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy.
Knutsen A; Adell G; Sun XF
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):149-55. PubMed ID: 15337550
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
[TBL] [Abstract][Full Text] [Related]
60. [Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer].
Wang GQ; Lu ZH; Fang YJ; Chen G; Zhou ZW; Pan ZZ; Wan DS
Ai Zheng; 2009 Sep; 28(9):945-9. PubMed ID: 19728912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
